Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Abstract:

:Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening malignancy in children, with current survival rates of ∼70%. State-of-the-art recommendations in adult AML have recently been published in this journal by Döhner et al. The primary goal of an international expert panel of the International BFM Study Group AML Committee was to set standards for the management, diagnosis, response assessment, and treatment in childhood AML. This paper aims to discuss differences between childhood and adult AML, and to highlight recommendations that are specific to children. The particular relevance of new diagnostic and prognostic molecular markers in pediatric AML is presented. The general management of pediatric AML, the management of specific pediatric AML cohorts (such as infants) or subtypes of the disease occurring in children (such as Down syndrome related AML), as well as new therapeutic approaches, and the role of supportive care are discussed.

journal_name

Blood

journal_title

Blood

authors

Creutzig U,van den Heuvel-Eibrink MM,Gibson B,Dworzak MN,Adachi S,de Bont E,Harbott J,Hasle H,Johnston D,Kinoshita A,Lehrnbecher T,Leverger G,Mejstrikova E,Meshinchi S,Pession A,Raimondi SC,Sung L,Stary J,Zwaan CM,K

doi

10.1182/blood-2012-03-362608

subject

Has Abstract

pub_date

2012-10-18 00:00:00

pages

3187-205

issue

16

eissn

0006-4971

issn

1528-0020

pii

blood-2012-03-362608

journal_volume

120

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

    abstract::Treatment outcomes for older patients with acute myeloid leukemia (AML) have remained dismal. This randomized, phase 2 trial in AML patients not considered suitable for intensive induction therapy compared low-dose cytarabine (LDAC) with or without volasertib, a highly potent and selective inhibitor of polo-like kinas...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-03-560557

    authors: Döhner H,Lübbert M,Fiedler W,Fouillard L,Haaland A,Brandwein JM,Lepretre S,Reman O,Turlure P,Ottmann OG,Müller-Tidow C,Krämer A,Raffoux E,Döhner K,Schlenk RF,Voss F,Taube T,Fritsch H,Maertens J

    更新日期:2014-08-28 00:00:00

  • Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

    abstract::The complex of the serine protease factor IX (FIX) and its cofactor, factor VIII (FVIII), is crucial for propagation of the intrinsic coagulation cascade. Absence of either factor leads to hemophilia, a disabling disorder marked by excessive hemorrhage after minor trauma. FVIII is the more commonly affected protein, e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-353672

    authors: Milanov P,Ivanciu L,Abriss D,Quade-Lyssy P,Miesbach W,Alesci S,Tonn T,Grez M,Seifried E,Schüttrumpf J

    更新日期:2012-01-12 00:00:00

  • Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.

    abstract::CRLF2 rearrangements, JAK1/2 point mutations, and JAK2 fusion genes have been identified in Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), a recently described subtype of pediatric high-risk B-precursor ALL (B-ALL) which exhibits a gene expression profile similar to Ph-positive ALL and has a poo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-03-415448

    authors: Maude SL,Tasian SK,Vincent T,Hall JW,Sheen C,Roberts KG,Seif AE,Barrett DM,Chen IM,Collins JR,Mullighan CG,Hunger SP,Harvey RC,Willman CL,Fridman JS,Loh ML,Grupp SA,Teachey DT

    更新日期:2012-10-25 00:00:00

  • A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.

    abstract::The mechanisms responsible for the low factor VIII (fVIII) activity in the plasma of patients with mild/moderate hemophilia A are poorly understood. In such patients, we have identified a series of fVIII mutations (Ile2098Ser, Ser2119Tyr, Asn2129Ser, Arg2150His, and Pro2153Gln) clustered in the C1 domain and associate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jacquemin M,Lavend'homme R,Benhida A,Vanzieleghem B,d'Oiron R,Lavergne JM,Brackmann HH,Schwaab R,VandenDriessche T,Chuah MK,Hoylaerts M,Gilles JG,Peerlinck K,Vermylen J,Saint-Remy JM

    更新日期:2000-08-01 00:00:00

  • Asrij/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence.

    abstract::Inactivation of the tumor suppressor p53 is essential for unrestrained growth of cancers. However, only 11% of hematological malignancies have mutant p53. Mechanisms that cause wild-type p53 dysfunction and promote leukemia are inadequately deciphered. The stem cell protein Asrij/OCIAD1 is misexpressed in several huma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000530

    authors: Sinha S,Dwivedi TR,Yengkhom R,Bheemsetty VA,Abe T,Kiyonari H,VijayRaghavan K,Inamdar MS

    更新日期:2019-05-30 00:00:00

  • Dangerous small B-cell clones.

    abstract::The detection of a monoclonal immunoglobulin in serum or urine usually raises concerns about the size of the underlying B-cell-derived clone and possible systemic effects caused by its expansion. However, a small clone can synthesize a very toxic protein, producing devastating systemic damage and protean clinical pres...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-03-001164

    authors: Merlini G,Stone MJ

    更新日期:2006-10-15 00:00:00

  • Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.

    abstract::Our previous study demonstrated that 2-methoxyestradiol (2ME2), an estrogen derivative, induces apoptosis in multiple myeloma (MM) cells; however, the related transcriptional events are unclear. In the present study, we used oligonucleotide microarrays to identify genes altered during 2ME2-induced apoptosis in MM cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3146

    authors: Chauhan D,Li G,Auclair D,Hideshima T,Richardson P,Podar K,Mitsiades N,Mitsiades C,Li C,Kim RS,Munshi N,Chen LB,Wong W,Anderson KC

    更新日期:2003-05-01 00:00:00

  • In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.

    abstract::One major obstacle to the effective treatment of cancer is to distinguish between tumor cells and normal cells. The chimeric molecules created by cancer-associated chromosomal abnormalities are ideal therapeutic targets because they are unique to the disease. We describe the use of a novel approach based on the cataly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cobaleda C,Sánchez-García I

    更新日期:2000-02-01 00:00:00

  • Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.

    abstract::Telomere length has been linked to disease stage and degree of (pan-)cytopenia in patients with bone marrow failure syndromes. The aim of the current study was to analyze the impact of replicative stress on telomere length in residual glycosylphosphatidylinositol-positive (GPI+) versus GPI- hematopoiesis in patients w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3996

    authors: Beier F,Balabanov S,Buckley T,Dietz K,Hartmann U,Rojewski M,Kanz L,Schrezenmeier H,Brümmendorf TH

    更新日期:2005-07-15 00:00:00

  • BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase.

    abstract::BCR-ABL antisense oligodeoxynucleotides (ODN) have provided evidence of antileukemia effect when tested in vitro against Philadelphia-positive (Ph-pos) cells and in vivo when injected into leukemic mice. On the basis of the results obtained in vitro at diagnosis, eight patients with chronic myelogenous leukemia (CML) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Fabritiis P,Petti MC,Montefusco E,De Propris MS,Sala R,Bellucci R,Mancini M,Lisci A,Bonetto F,Geiser T,Calabretta B,Mandelli F

    更新日期:1998-05-01 00:00:00

  • Selection of patients for bone marrow transplantation in severe aplastic anemia.

    abstract::Despite androgens and intensive supportive care, satisfactory survival in severe aplastic anemia remains at 20% or less. Histocompatible bone marrow transplantation can restore normal hematopoiesis in approximately 40% of similarly severe individuals. Delay of transplantation for 3 wk after diagnosis allows time for p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Camitta BM,Rappeport JM,Parkman R,Nathan DG

    更新日期:1975-03-01 00:00:00

  • Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.

    abstract::Understanding leukemia heterogeneity is critical for the development of curative treatments as the failure to eliminate therapy-persistent leukemic stem cells (LSCs) may result in disease relapse. Here we have combined high-throughput immunophenotypic screens with large-scale single-cell gene expression analysis to de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-728873

    authors: Warfvinge R,Geironson L,Sommarin MNE,Lang S,Karlsson C,Roschupkina T,Stenke L,Stentoft J,Olsson-Strömberg U,Hjorth-Hansen H,Mustjoki S,Soneji S,Richter J,Karlsson G

    更新日期:2017-04-27 00:00:00

  • Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.

    abstract::Sixteen patients with adult T-cell leukemia/lymphoma (ATL) who were all over 50 years of age underwent allogeneic stem cell transplantation with reduced-conditioning intensity (RIST) from HLA-matched sibling donors after a conditioning regimen consisting of fludarabine (180 mg/m2), busulfan (8 mg/kg), and rabbit antit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4193

    authors: Okamura J,Utsunomiya A,Tanosaki R,Uike N,Sonoda S,Kannagi M,Tomonaga M,Harada M,Kimura N,Masuda M,Kawano F,Yufu Y,Hattori H,Kikuchi H,Saburi Y

    更新日期:2005-05-15 00:00:00

  • Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

    abstract::In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolthers KC,Otto SA,Wisman GB,Fleury S,Reiss P,ten Kate RW,van der Zee AG,Miedema F

    更新日期:1999-02-01 00:00:00

  • DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

    abstract::The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8(+) cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLA-B*2705-restricted H-Y antigen encoded by the DDX3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-096313

    authors: Rosinski KV,Fujii N,Mito JK,Koo KK,Xuereb SM,Sala-Torra O,Gibbs JS,Radich JP,Akatsuka Y,Van den Eynde BJ,Riddell SR,Warren EH

    更新日期:2008-05-01 00:00:00

  • Gamma heavy chain disease: rapid, sustained response to cyclophosphamide and prednisone.

    abstract::A patient, CAL, with gamma heavy chain disease is presented who has had a complete remission lasting over 2 yr with combination chemotherapy consisting of pulsatile cyclophosphamide and prednisone. The patient exhibited many features of an atuoimmune process including a vasculitis, low serum complement levels, a posit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lyons RM,Chaplin H,Tillack TW,Majerus PW

    更新日期:1975-07-01 00:00:00

  • Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

    abstract::Recent molecular analyses of leukemic blasts from pretreatment marrow or blood of patients with acute myeloid leukemia (AML) and a normal karyotype, the largest cytogenetic subset (ie, 40%-49%) of AML, have revealed a striking heterogeneity with regard to the presence of acquired gene mutations and changes in gene exp...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-06-001149

    authors: Mrózek K,Marcucci G,Paschka P,Whitman SP,Bloomfield CD

    更新日期:2007-01-15 00:00:00

  • Hepatosplenic T-cell lymphoma: a rare but challenging entity.

    abstract::Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004118

    authors: Pro B,Allen P,Behdad A

    更新日期:2020-10-29 00:00:00

  • Role of ADP receptors on platelets in the growth of ovarian cancer.

    abstract::We investigated the effect of platelets on ovarian cancer and the role of adenosine diphosphate (ADP) receptors (P2Y12 and P2Y1) on platelets in the growth of primary ovarian cancer tumors. We showed that in murine models of ovarian cancer, a P2Y12 inhibitor (ticagrelor) reduced tumor growth by 60% compared with aspir...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-02-769893

    authors: Cho MS,Noh K,Haemmerle M,Li D,Park H,Hu Q,Hisamatsu T,Mitamura T,Mak SLC,Kunapuli S,Ma Q,Sood AK,Afshar-Kharghan V

    更新日期:2017-09-07 00:00:00

  • Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets.

    abstract::Human platelets are aggregated and induced to release their granule contents and form thromboxane by peptides as short as 6-amino acid residues (SFLLRN) corresponding to the newly released N-terminus of the thrombin receptor that is cleaved by thrombin. Using washed platelets, we found that these responses to SFLLRN (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kinlough-Rathbone RL,Rand ML,Packham MA

    更新日期:1993-07-01 00:00:00

  • Leptin stimulates fetal and adult erythroid and myeloid development.

    abstract::The ob gene product, leptin, has been shown in several studies to be involved in weight control and recombinant leptin recently has entered clinical trials to treat obesity. The leptin receptor (OB-R/B219) is expressed in a variety of protein isoforms not only in the central nervous system, but also in reproductive, a...

    journal_title:Blood

    pub_type: 杂志文章,收录出版

    doi:

    authors: Mikhail AA,Beck EX,Shafer A,Barut B,Gbur JS,Zupancic TJ,Schweitzer AC,Cioffi JA,Lacaud G,Ouyang B,Keller G,Snodgrass HR

    更新日期:1997-03-01 00:00:00

  • Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected.

    abstract::Human herpesvirus 8 (HHV-8) genomic sequences were recently detected by polymerase chain reaction (PCR) and in situ hybridization in bone marrow stromal cells grown from multiple myeloma (MM) patients, but not in cells from control subjects (Rettig et al, Science 276:1851, 1997). We sought to confirm these observation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tisdale JF,Stewart AK,Dickstein B,Little RF,Dubé I,Cappe D,Dunbar CE,Brown KE

    更新日期:1998-10-15 00:00:00

  • Gadd45a regulates hematopoietic stem cell stress responses in mice.

    abstract::Gadd45a has been involved in DNA damage response and in many malignancies, including leukemia. However, the function of Gadd45a in hematopoietic stem cells (HSCs) remains unknown. Here, we reported that Gadd45a-deficient (Gadd45a(-/-)) mice showed a normal hematologic phenotype under homeostatic conditions. However, f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-504084

    authors: Chen Y,Ma X,Zhang M,Wang X,Wang C,Wang H,Guo P,Yuan W,Rudolph KL,Zhan Q,Ju Z

    更新日期:2014-02-06 00:00:00

  • Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis.

    abstract::The EEN (extra eleven nineteen) gene, located on chromosome 19p13, was cloned as a fusion with MLL from a patient with acute myeloid leukemia (AML) with translocation t(11;19)(q23;p13). In this study, we characterized the genomic structure of the EEN gene, including its 5' regulatory region and transcription start sit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-003517

    authors: Ma LH,Liu H,Xiong H,Chen B,Zhang XW,Wang YY,Le HY,Huang QH,Zhang QH,Li BL,Chen Z,Chen SJ

    更新日期:2007-01-15 00:00:00

  • Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice.

    abstract::Erythroid Kruppel-like factor (EKLF) is a transcription factor of the C2H2 zinc-finger class that is essential for definitive erythropoiesis. We generated immortal erythroid cell lines from EKLF(-/-) fetal liver progenitor cells that harbor a single copy of the entire human beta-globin locus and then reintroduced EKLF...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.6.1861

    authors: Coghill E,Eccleston S,Fox V,Cerruti L,Brown C,Cunningham J,Jane S,Perkins A

    更新日期:2001-03-15 00:00:00

  • The histone demethylase UTX regulates stem cell migration and hematopoiesis.

    abstract::Regulated migration of hematopoietic stem cells is fundamental for hematopoiesis. The molecular mechanisms underlying stem cell trafficking are poorly defined. Based on a short hairpin RNA library and stromal cell-derived factor-1 (SDF-1) migration screening assay, we identified the histone 3 lysine 27 demethylase UTX...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-452003

    authors: Thieme S,Gyárfás T,Richter C,Özhan G,Fu J,Alexopoulou D,Muders MH,Michalk I,Jakob C,Dahl A,Klink B,Bandola J,Bachmann M,Schröck E,Buchholz F,Stewart AF,Weidinger G,Anastassiadis K,Brenner S

    更新日期:2013-03-28 00:00:00

  • HLA associations with leukemia.

    abstract::Frequencies of 35 HLA A, B, C, and DR antigens were determined in 1,834 leukemic Caucasoids to evaluate possible associations between HLA and leukemia. In comparison with the frequencies of HLA antigens in published controls, the frequency of Cw3 was significantly higher in patients with acute lymphoblastic leukemia (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bortin MM,D'Amaro J,Bach FH,Rimm AA,van Rood JJ

    更新日期:1987-07-01 00:00:00

  • Transformation of Fanconi's anemia to acute nonlymphocytic leukemia associated with emergence of monosomy 7.

    abstract::Two sisters in whom a diagnosis of Fanconi's anemia was made at ages 12 and 18 subsequently developed acute nonlymphocytic leukemia (ANLL). A third sibling had previously died at age 11 of apparent sepsis. Both sisters had cytogenetic studies that showed increased chromosomal breakage and a 46,XX karyotype, but subseq...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stivrins TJ,Davis RB,Sanger W,Fritz J,Purtilo DT

    更新日期:1984-07-01 00:00:00

  • Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

    abstract::Activation of plasminogen, the zymogen of the primary thrombolytic enzyme, plasmin, is markedly promoted when plasminogen is bound to cell surfaces, arming cells with the broad spectrum proteolytic activity of plasmin. In addition to its role in thrombolysis, cell surface plasmin facilitates a wide array of physiologi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-188938

    authors: Andronicos NM,Chen EI,Baik N,Bai H,Parmer CM,Kiosses WB,Kamps MP,Yates JR 3rd,Parmer RJ,Miles LA

    更新日期:2010-02-18 00:00:00

  • Varying intensity of postremission therapy in acute myeloid leukemia.

    abstract::The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would improve the outcome. After uniform induction therapy, patients in com...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Cassileth PA,Lynch E,Hines JD,Oken MM,Mazza JJ,Bennett JM,McGlave PB,Edelstein M,Harrington DP,O'Connell MJ

    更新日期:1992-04-15 00:00:00